Richard Kraemer

2.9k total citations
77 papers, 2.0k citations indexed

About

Richard Kraemer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Richard Kraemer has authored 77 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Richard Kraemer's work include Cystic Fibrosis Research Advances (42 papers), Neonatal Respiratory Health Research (31 papers) and Inhalation and Respiratory Drug Delivery (20 papers). Richard Kraemer is often cited by papers focused on Cystic Fibrosis Research Advances (42 papers), Neonatal Respiratory Health Research (31 papers) and Inhalation and Respiratory Drug Delivery (20 papers). Richard Kraemer collaborates with scholars based in Switzerland, Germany and United States. Richard Kraemer's co-authors include A Rüdeberg, Sabina Gallati, P. Birrer, E. Rossi, B. Hadorn, Urs Frey, Sabina Liechti‐Gallati, Andreas Schibler, Ronald G. Crystal and Noel G. McElvaney and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

Richard Kraemer

73 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Kraemer Switzerland 23 1.7k 433 233 163 150 77 2.0k
Lena Hjelte Sweden 24 1.3k 0.8× 228 0.5× 253 1.1× 176 1.1× 128 0.9× 86 1.9k
K. Brownlee United Kingdom 23 1.7k 1.0× 177 0.4× 334 1.4× 255 1.6× 115 0.8× 67 2.2k
Gary Connett United Kingdom 26 1.1k 0.6× 481 1.1× 235 1.0× 321 2.0× 72 0.5× 102 1.7k
Casilda Olveira Spain 31 2.5k 1.5× 513 1.2× 504 2.2× 116 0.7× 119 0.8× 94 2.8k
H. von der Hardt Germany 30 2.0k 1.2× 266 0.6× 320 1.4× 337 2.1× 170 1.1× 98 2.8k
Anders Lindblad Sweden 25 2.1k 1.2× 334 0.8× 559 2.4× 375 2.3× 99 0.7× 80 2.7k
Richard C. Ahrens United States 25 2.4k 1.4× 1.1k 2.6× 164 0.7× 133 0.8× 118 0.8× 60 2.8k
Margaret F. Guill United States 16 821 0.5× 224 0.5× 155 0.7× 133 0.8× 127 0.8× 39 1.3k
C. Michael Bowman United States 19 1.5k 0.9× 191 0.4× 344 1.5× 201 1.2× 52 0.3× 39 1.9k
J M Littlewood United Kingdom 26 1.6k 0.9× 166 0.4× 400 1.7× 495 3.0× 265 1.8× 72 2.5k

Countries citing papers authored by Richard Kraemer

Since Specialization
Citations

This map shows the geographic impact of Richard Kraemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kraemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kraemer more than expected).

Fields of papers citing papers by Richard Kraemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Kraemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kraemer. The network helps show where Richard Kraemer may publish in the future.

Co-authorship network of co-authors of Richard Kraemer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kraemer. A scholar is included among the top collaborators of Richard Kraemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kraemer. Richard Kraemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kraemer, Richard, Florent Baty, Hans‐Jürgen Smith, et al.. (2024). Assessment of functional diversities in patients with Asthma, COPD, Asthma-COPD overlap, and Cystic Fibrosis (CF). PLoS ONE. 19(2). e0292270–e0292270.
3.
4.
Latzin, Philipp, Cindy Thamrin, Andreas Schibler, et al.. (2007). Optimized temperature and deadspace correction improve analysis of multiple breath washout measurements by ultrasonic flowmeter in infants. Pediatric Pulmonology. 42(10). 888–897. 57 indexed citations
5.
Kraemer, Richard, et al.. (2006). Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 174(11). 1211–1220. 142 indexed citations
6.
Kraemer, Richard, Andrea Blum, Andreas Schibler, Roland A. Ammann, & Sabina Gallati. (2004). Ventilation Inhomogeneities in Relation to Standard Lung Function in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 171(4). 371–378. 127 indexed citations
7.
Frey, Urs, Michael Silverman, Richard Kraemer, & A. Jackson. (1998). High-frequency Respiratory Impedance Measured by Forced-Oscillation Technique in Infants. American Journal of Respiratory and Critical Care Medicine. 158(2). 363–370. 27 indexed citations
8.
Liechti‐Gallati, Sabina & Richard Kraemer. (1995). Cystic fibrosis mutations and immotile cilia syndrome. Clinical Genetics. 47(6). 328–329. 3 indexed citations
9.
Liechti‐Gallati, Sabina, et al.. (1995). Chronic Metabolic Alkalosis: Not Uncommon in Young Children with Severe Cystic Fibrosis. American Journal of Nephrology. 15(3). 245–250. 13 indexed citations
10.
Aebi, Christoph, et al.. (1995). The age at onset of chronicPseudomonas aeruginosa colonization in cystic fibrosis —prognostic significance. European Journal of Pediatrics. 154(S4). S69–S73. 34 indexed citations
11.
Birrer, P., Noel G. McElvaney, A Rüdeberg, et al.. (1994). Protease-Antiprotease Imbalance in the Lungs of Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 150(1). 207–213. 315 indexed citations
12.
Kraemer, Richard. (1993). Assessment of Functional Abnormalities in Infants and Children with Lung Disease. Birkhäuser Basel eBooks. 40. 41–55. 5 indexed citations
13.
Schöni, Martin H., et al.. (1990). Abnormal 3,4‐dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis. European Journal of Clinical Investigation. 20(3). 272–278.
14.
Schaad, U. B., et al.. (1989). Antipseudomonal therapy in cystic fibrosis: Aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 8(10). 858–865. 36 indexed citations
15.
Kraemer, Richard, et al.. (1988). Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases. European Journal of Clinical Pharmacology. 34(4). 339–342. 10 indexed citations
16.
Bianchetti, M G, et al.. (1988). Use of Salivary Levels to Predict Clearance of Caffeine in Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 7(5). 688–693. 1 indexed citations
17.
Kraemer, Richard, et al.. (1986). [Epidemiologic aspects of bronchial asthma in childhood].. PubMed. 116(36). 1210–6. 3 indexed citations
18.
Kraemer, Richard. (1982). Onset of pulmonary involvement in cystic fibrosis. European Journal of Pediatrics. 139(4). 239–239. 2 indexed citations
19.
Kraemer, Richard, et al.. (1979). Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis.. PubMed. 34(5). 417–28. 23 indexed citations
20.
Kraemer, Richard, B. Hadorn, & Emanuela Rossi. (1977). Classification at time of diagnosis and subsequent survival in children with cystic fibrosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(2). 107–14. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lena Hjelte Breakdown of academic impact, for papers by K. Brownlee Breakdown of academic impact, for papers by Gary Connett Breakdown of academic impact, for papers by Casilda Olveira Breakdown of academic impact, for papers by H. von der Hardt Breakdown of academic impact, for papers by Anders Lindblad Breakdown of academic impact, for papers by Richard C. Ahrens Breakdown of academic impact, for papers by Margaret F. Guill Breakdown of academic impact, for papers by C. Michael Bowman Breakdown of academic impact, for papers by J M Littlewood
Rankless by CCL
2026